Utilization of solid nanomaterials for drug delivery

Miles F. Beaux, David N. McIlroy, Kurt E Gustin

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background: Solid nanostructures are versatile platforms for constructing hybrid drug delivery systems that have tremendous potential for improving disease prevention and treatment. The rationale and application of solid nanostructures in the context of drug delivery are explored in this article. Objective: The purpose of this paper is to provide a concise review of the major attributes of solid nanostructures as they relate to drug delivery and to describe the outstanding issues that need to be addressed in order to develop these materials into clinically useful reagents. Methods: The scope of this opinion has been restricted to solid nanostructures, where solid nanostructures are defined as those that are not biodegradable. The opinion has been further limited to the three primary types of nanostructures: nanoparticles, nanowires and nanotubes. Results/conclusion: There is a need for cross-disciplinary training and standardized protocols for developing and evaluating the efficacy of solid nanomaterials.

Original languageEnglish (US)
Pages (from-to)725-735
Number of pages11
JournalExpert Opinion on Drug Delivery
Volume5
Issue number7
DOIs
StatePublished - Jul 2008
Externally publishedYes

Fingerprint

Nanostructures
Pharmaceutical Preparations
Nanowires
Nanotubes
Drug Delivery Systems
Nanoparticles

Keywords

  • Nanomaterials
  • Nanoparticles
  • Nanotoxicology
  • Nanowires

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Utilization of solid nanomaterials for drug delivery. / Beaux, Miles F.; McIlroy, David N.; Gustin, Kurt E.

In: Expert Opinion on Drug Delivery, Vol. 5, No. 7, 07.2008, p. 725-735.

Research output: Contribution to journalArticle

Beaux, Miles F. ; McIlroy, David N. ; Gustin, Kurt E. / Utilization of solid nanomaterials for drug delivery. In: Expert Opinion on Drug Delivery. 2008 ; Vol. 5, No. 7. pp. 725-735.
@article{98ca65bed4c44a1d95da64e05144baa5,
title = "Utilization of solid nanomaterials for drug delivery",
abstract = "Background: Solid nanostructures are versatile platforms for constructing hybrid drug delivery systems that have tremendous potential for improving disease prevention and treatment. The rationale and application of solid nanostructures in the context of drug delivery are explored in this article. Objective: The purpose of this paper is to provide a concise review of the major attributes of solid nanostructures as they relate to drug delivery and to describe the outstanding issues that need to be addressed in order to develop these materials into clinically useful reagents. Methods: The scope of this opinion has been restricted to solid nanostructures, where solid nanostructures are defined as those that are not biodegradable. The opinion has been further limited to the three primary types of nanostructures: nanoparticles, nanowires and nanotubes. Results/conclusion: There is a need for cross-disciplinary training and standardized protocols for developing and evaluating the efficacy of solid nanomaterials.",
keywords = "Nanomaterials, Nanoparticles, Nanotoxicology, Nanowires",
author = "Beaux, {Miles F.} and McIlroy, {David N.} and Gustin, {Kurt E}",
year = "2008",
month = "7",
doi = "10.1517/17425247.5.7.725",
language = "English (US)",
volume = "5",
pages = "725--735",
journal = "Expert Opinion on Drug Delivery",
issn = "1742-5247",
publisher = "Informa Healthcare",
number = "7",

}

TY - JOUR

T1 - Utilization of solid nanomaterials for drug delivery

AU - Beaux, Miles F.

AU - McIlroy, David N.

AU - Gustin, Kurt E

PY - 2008/7

Y1 - 2008/7

N2 - Background: Solid nanostructures are versatile platforms for constructing hybrid drug delivery systems that have tremendous potential for improving disease prevention and treatment. The rationale and application of solid nanostructures in the context of drug delivery are explored in this article. Objective: The purpose of this paper is to provide a concise review of the major attributes of solid nanostructures as they relate to drug delivery and to describe the outstanding issues that need to be addressed in order to develop these materials into clinically useful reagents. Methods: The scope of this opinion has been restricted to solid nanostructures, where solid nanostructures are defined as those that are not biodegradable. The opinion has been further limited to the three primary types of nanostructures: nanoparticles, nanowires and nanotubes. Results/conclusion: There is a need for cross-disciplinary training and standardized protocols for developing and evaluating the efficacy of solid nanomaterials.

AB - Background: Solid nanostructures are versatile platforms for constructing hybrid drug delivery systems that have tremendous potential for improving disease prevention and treatment. The rationale and application of solid nanostructures in the context of drug delivery are explored in this article. Objective: The purpose of this paper is to provide a concise review of the major attributes of solid nanostructures as they relate to drug delivery and to describe the outstanding issues that need to be addressed in order to develop these materials into clinically useful reagents. Methods: The scope of this opinion has been restricted to solid nanostructures, where solid nanostructures are defined as those that are not biodegradable. The opinion has been further limited to the three primary types of nanostructures: nanoparticles, nanowires and nanotubes. Results/conclusion: There is a need for cross-disciplinary training and standardized protocols for developing and evaluating the efficacy of solid nanomaterials.

KW - Nanomaterials

KW - Nanoparticles

KW - Nanotoxicology

KW - Nanowires

UR - http://www.scopus.com/inward/record.url?scp=48449096041&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=48449096041&partnerID=8YFLogxK

U2 - 10.1517/17425247.5.7.725

DO - 10.1517/17425247.5.7.725

M3 - Article

C2 - 18590458

AN - SCOPUS:48449096041

VL - 5

SP - 725

EP - 735

JO - Expert Opinion on Drug Delivery

JF - Expert Opinion on Drug Delivery

SN - 1742-5247

IS - 7

ER -